top of page

Are you struggling with your surgical robot? Are you finding challenges with your complex medical device? Need external experts to take a look and help you? Team Purple has you covered...

 

Search

What to expect in soft tissue surgical robotics 2025

Updated: Jul 30, 2025

I'm going to just get out my crystal ball here - this will be 100% just pure guesses based off general zeitgeist in the market - reviewing some patent stuff - watching hiring announcements - watching linked in - seeing some regulatory documents etc etc.



Speculation on what to expect in soft tissue surgical robotics 2025
Speculation on what to expect in soft tissue surgical robotics 2025



But here is what I'm predicting as a short list for 2025... maybe some are wild.



1) IntuItive daVinci 5 gets CE mark early Q2 - for a June launch in select European markets 2) Medicaroid Hinatori gets CE mark Q3

3) Medtronic Hugo gets FDA clearance for Urology / prostate Q1 2025, Gynaecological expansion Q3 4) Medtronic Hugo gets first commercial cases USA Q1, first commercial sales USA Q2 5) Medtronic Hugo gets CE mark on Ligasure and Beta release Q2, and on Stapling Q4 6) CMR Surgical Versius - First US Clinical cases Q1 2025 and first commercial progress USA Q2 2025


7) Stryker makes a bid to acquire a soft tissue robot Q2 2025 - concludes by Q4 2025 - Moon or Distal...


8) JNJ Ottava starts first IDE cases Q1 2025


9) Virtual Incision gets procedural expansion and announces a smaller diameter MIRA system 2025


10) Moon Surgical gets significant upgrades in their vision system analytics and adds more automation features by Q3 2025 (USA)

11) DistalMotion Dexter gets first commercial traction into ASCs Q1 2025

12) SS Innovations gets FDA clearance Q3 2025 with limited indications

13) Toumai gets FDA clearance Q4 2025 with quite broad indications as Xi as predicate 14) Vicarious Surgical submits for IDE 2025

15) Bitrack expands EU commercial footprint throughout 2025

16) Toumai gets first western European sales Q2 2025 17) Intuitive announces the retrofit of the DV5 tower and compatibility to Xi, X and SP - Q3 2025 - but with some nixed functionality like no haptics (This is super wild speculation) 18) Telerobotics gains more traction than people think and it becomes more important as a core feature of systems in tenders and contracting


19) The stapler battle heats up with a faster movement to robotic based stapling than predicted putting pressure on hand held staplers


20) AI features of scene analysis and perioperative assistance start to drop into systems more widely - pushed by Intuitive


21) The market moves to 95% Lease / PPC / structured models and capital up front all but collapses putting pressure on all balance sheets - except Intuitive.


22) The market starts to consolidate with some acquisitions and some companies deciding to exit the race. The number of "available" systems drops.


23) Investment into the space hits a low throughout 2025 as investors question about the returns so far in this specific space. Money moves to other robotic spaces. (and cardiac.)


24) Several new adjunct "tuck in" technologies get acquired by JNJ, MDT, ISRG to bolster their offering and strengthen their robotic platforms.


25) "THE TOWER" becomes an even more important area of focus as companies strive to gain the broader hand held lap and robotic dominance - especially in places like ASCs


26) Data ecosystems become better and more powerful and insights start to drive purchase decisions more than it being seen as an "add on." The data now spans the laparoscopic and robotic cases to start to give deeper hospital insights.

27) Companies will start to strategise deeper on portfolios - and if they need base / entry level systems - besides single port solutions - besides higher end systems to be able to compete as the markets starts to segment globally.


28) Several Chinese companies realise the vast expense - resistance - and resources outside of China and by Q4 2025 only a few will be set to compete outside of China in a meaningful way. The rest retreat back into china.


29) As Robotic Ligasure hits the market - the battle for advanced energy on robots heats up with more articulating energy devices being trialled or even released by Q4 2025. Intuitive upgrades Synchroseal.


30) A sudden global "talent" race will accelerate above and beyond 2024 - as companies understand there are uber specialists that are the catalyst that can drive strategies - and local implementation. Direct employees and distributor "pools" will dry up - and companies will struggle to get the people resources they need.


31) Bonus speculation - Intuitive drop news on hand held stapling and energy.




These are 100% speculations by the author based solely on publicly available intelligence - trends - and information. This is for educational purposes only and should not be relied upon for any other reason.


Get the Ultimate Medtech Survival Guide now

Copyright & Fair Use Notice

All content on this website is the copyright of Steve Bell S.R.L. and remains the proprietary property of the authors. This site utilizes third-party media in good faith for educational commentary and transformative analysis under Fair Use provisions.

1. Mandatory Notice and Takedown: I respect intellectual property. If you believe any material is used outside of fair use, your sole and exclusive remedy is to contact steve@howtostartupinmedtech.com for immediate removal. I will act promptly on any reasonable request.

2. Prohibition of Automated Enforcement: I explicitly prohibit the use of automated "copyright enforcement" bots (including but not limited to PicRights, Copytrack, Pixsy, AP, or Reuters bots) to scrape this site for speculative invoicing.

3. GDPR & Contractual Agreement: By bypassing technical headers (robots.txt) or scraping this site, you (the "Scraper") enter into a binding legal contract with Steve Bell S.R.L. You acknowledge that this site contains my Personally Identifiable Information (PII) and personal likeness. As a result:

You are legally deemed a Data Processor under EU GDPR.

Any automated claim sent to Steve Bell S.R.L. or Steve Bell  must be accompanied by a full Article 15 Disclosure Report detailing exactly how my PII was processed and whether it was transferred outside the EEA.

Failure to provide this report or bypassing my technical blocks will be reported to the Italian Data Protection Authority (Garante per la protezione dei dati personali) as a breach of privacy law.

Anti-Scraping & Automated Enforcement Clause

Contractual Agreement: By bypassing technical headers (robots.txt) or scraping this site to generate a claim, you (the Scraper) explicitly enter into a binding contract with Steve Bell S.R.L. You agree to waive all automated "settlement" fees in favor of the Notice and Takedown protocol above.

Reinforced statement: GDPR & International Data Transfer: This site contains my personal likeness and identifiable data (PII). Any entity scraping this data becomes a Data Processor under EU law. Any automated claim must be accompanied by a full GDPR Article 15 report detailing where my PII is stored and confirming compliance with international data transfer regulations (EEA to non-EEA). Unauthorized processing will be reported to the Garante per la protezione dei dati personali.

Notice to scraping services: Please read the scraping policy 

How to start a medtech company

©2023-2026 by How to Startup in MedTech 

Steve Bell S.R.L. (unipersonale) – Sede legale: Via Nalles 95, 00124 Roma (RM)  Italy

P.IVA / C.F. 18199441009  – REA RM- 1768831  – Cap. Soc. €10.000 i.v. – PEC: stevebellsrl@pec.it

bottom of page